LEAP THERAPEUTICS, INC. — Director's Dealing 2017

Jan 24, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEAP THERAPEUTICS, INC. (LPTX)
CIK: 0001509745
Period of Report: 2017-01-23

Reporting Person: LAWLOR AUGUSTINE (Chief Operating Officer, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-01-23	Stock Option (Right to Buy)	$9.90	A	330303	Acquired	2027-01-22	Common Stock, $0.001 par value per share (330303)	Direct

Footnotes

F1: The Option was granted pursuant to Leap's Amended and Restated 2012 Equity Incentive Plan and shall vest and become exercisable with respect to 33 1/3% of the Option Shares on the one-year anniversary of January 23, 2017, the Vesting Start Date (the "First Vesting Date"), after which it shall vest in a series of 24 equal monthly installments until the Option is fully vested, with the first such monthly installment vesting on the one-month anniversary of the First Vesting Date.